Top Story

Early noninvasive testing did not impact MI rate in patients with chest pain

January 26, 2015

For patients presenting to the ED with chest pain but no MI, the rate of short-term future MI was low and was not affected by early noninvasive testing.

Researchers conducted a retrospective cohort analysis of health insurance claims data for a national sample of privately insured patients with a primary or secondary diagnosis of chest pain in the ED in 2011.

FDA approves fixed-dose combination for patients with hypertension FDA approvals

FDA approves fixed-dose combination for patients with hypertension

January 26, 2015
Symplmed Pharmaceuticals announced that the FDA has approved the fixed-dose combination of perindopril arginine and amlodipine for the treatment of hypertension in…
FDA News

FDA accepts alirocumab for priority review

January 26, 2015
Sanofi and Regeneron announced that the FDA has accepted the companies’ Biologics License Application for the proprotein convertase subtilisin/kexin type 9…
In the Journals

Majority of PCPs assigned high value to medical imaging

January 26, 2015
The majority of primary care physicians considered access to medical imaging to be essential to patient care, indicating that it aided in establishing earlier and more…
Martin B. Leon, MD 5 Questions with Dr. Bhatt

A Conversation with Martin B. Leon, MD

Cardiology Today's Intervention, January/February 2015
For this issue, Dr. Bhatt talks with Martin B. Leon, MD, professor of medicine at Columbia University Medical Center, director of the Center for Interventional Vascular…
More News Headlines »
CME
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
thumbnail for video 3945938325001

Kirk N. Garratt, MD: Prolonged DAPT beneficial in patients with paclitaxel-eluting stents

December 16, 2014
CHICAGO — In this video, Kirk N. Garratt, MD, of the Lennox Hill Hospital, New York, outlines results of a study…
More »
CME
Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

This activity is supported by educational grants from Lilly USA, LLC and Novo Nordisk.

The prevalence of type 2 diabetes mellitus has escalated in recent years and targeting treatmentcontinues to be a…
More »
morganatic-roan
morganatic-roan